X1 Biotech Inc.

Amendment
CIK: 0002068848·Other Technology·DELAWARE·Filed: Dec 11, 2025
Total Offering

$300,000

Amount Sold

$95,000

Investors

5

First Sale

May 8, 2025

Offering Details

Type
Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)

Related Persons

NameRole
Lawrence Kaufman
Executive Officer
Michael Aceti
Executive Officer
Leo Kim
Director
Joseph Arboleda-Valasquez
Director
Dean Eliott
Director

Company

X1 Biotech Inc.

935 GREAT PLAIN AVENUE

NEEDHAM, MA, 02492

617-834-4833

SEC Filing

0002068848-25-000004

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
X1 Biotech Inc. Form D Filing — $300,000 | FilingFlow